+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody



In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody



Journal of Immunology 162(8): 4536-4541



B cell tolerance is maintained by active deletion and functional anergy of self-reactive B cells depending on the time, amount, and site of the self-antigen expression. To study B cell tolerance toward a transplacentally transmitted viral Ag, we crossed transgenic mice expressing the mu heavy and the kappa light chain of the lymphocytic choriomeningitis virus (LCMV)-neutralizing mAb KL25 (HL25-transgenic mice) with persistently infected LCMV carrier mice. Although HL25-transgenic LCMV carrier mice exhibited the same high virus titers as nontransgenic LCMV carrier mice, no evidence for B cell tolerance was found. In contrast, enhanced LCMV-neutralizing Ab titers were measured that, however, did not clear the virus. Instead, LCMV isolates from different tissues turned out to be neutralization resistant Ab escape variants expressing different substitutions of amino acid Asn119 of the LCMV-glycoprotein 1 that displays the neutralizing B cell epitope. Virus variants with the same mutations were also selected in vitro in the presence of the transgenic mAb KL25 confirming that substitutions of Asn119 have been selected by LCMV-neutralizing Abs. Thus, despite abundant expression of viral neo-self-antigen in HL25-transgenic LCMV carrier mice, transgenic B cells expressing LCMV-neutralizing Abs were rather stimulated than tolerized and neutralization resistant Ab escape variants were selected in vivo.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 017955314

Download citation: RISBibTeXText

PMID: 10201992


Related references

Immunological tolerance to lymphocytic choriomeningitis virus in neonatally infected virus carrier mice: evidence supporting a clonal inactivation mechanism. Immunology 34(2): 265-275, 1978

Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic mice. Journal of Virology 72(3): 2253-2258, 1998

Preferential selection of receptor-binding variants of influenza virus hemagglutinin by the neutralizing antibody repertoire of transgenic mice expressing a human immunoglobulin mu minigene. Journal of Virology 71(4): 2600-2605, 1997

Fatal central nervous system disease in lymphocytic choriomeningitis virus carrier mice given lymphocytic choriomeningitis virus immune donor spleen cells. Federation Proceedings 30(2): 353, 1971

Immunobiology of cytotoxic T-cell resistant virus variants Studies on lymphocytic choriomeningitis virus. Seminars in Virology 7(1): 3-11, 1996

The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-antibody complexes). Proceedings of the National Academy of Sciences of the United States of America 69(1): 134-138, 1972

The detection of neutralizing antibody to lymphocytic choriomeningitis virus in mice. Journal of Immunology 102(5): 1128-1135, 1969

A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proceedings of the National Academy of Sciences of the United States of America 94(13): 6874-6879, 1997

Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination. European Journal of Immunology 19(7): 1283-1288, 1989

Antiviral antibody production in parenchymatous organs of lymphocytic choriomeningitis virus carrier mice. Enumeration of antibody-producing cells and immunohistochemical investigation of mononuclear cell infiltrates. Medical Microbiology and Immunology 175(2-3): 113-116, 1986

The mechanism of neutralization of influenza virus by antibody evidence that neutralizing antibody anti hem agglutinin inactivates influenza virus in vivo by inhibiting virion transcriptase activity. Journal of General Virology 58(2): 373-386, 1982

Studies on the mechanism of neutralization of influenza virus by antibody: evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virus in vivo by inhibiting virion transcriptase activity. Journal of General Virology 58(Pt 2): 373-386, 1982

Lymphocytic choriomeningitis virus carrier mice factors determining virus persistence. Medicina (Buenos Aires) 37(Suppl. 3): 78-89, 1977

Lymphocytic choriomeningitis virus replication in lymphocytes of virus carrier mice. Journal of Supramolecular Structure 7(Suppl. 2): 244, 1978